Novonesis A S ADR (NVZMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 4,148,230 | 2,598,935 | 2,485,505 | 2,378,704 | 2,146,638 |
| Cost of Goods | 2,190,170 | 1,187,300 | 1,129,402 | 1,006,785 | 943,559 |
| Gross Profit | 1,958,060 | 1,411,634 | 1,356,103 | 1,371,919 | 1,203,080 |
| Operating Expenses | 1,416,098 | 834,620 | 710,667 | 735,191 | 644,152 |
| Operating Income | 542,132 | 577,315 | 645,838 | 637,514 | 559,486 |
| Interest Expense | 116,109 | 48,061 | 75,190 | 40,252 | 23,440 |
| Other Income | 25,321 | 38,333 | 74,482 | 27,047 | 3,370 |
| Pre-tax Income | 451,344 | 567,587 | 645,130 | 624,308 | 539,417 |
| Income Tax | 120,438 | 126,324 | 123,192 | 123,939 | 106,474 |
| Net Income Continuous | 330,906 | 441,263 | 521,938 | 500,370 | 432,943 |
| Minority Interests | N/A | 2,178 | 1,416 | -159 | 153 |
| Net Income | $330,906 | $439,085 | $520,522 | $500,529 | $432,790 |
| EPS Basic Total Ops | 0.73 | 1.59 | 1.88 | 1.80 | 1.54 |
| EPS Basic Continuous Ops | 0.72 | 1.59 | 1.89 | 1.80 | 1.54 |
| EPS Diluted Total Ops | 0.73 | 1.58 | 1.87 | 1.79 | 1.54 |
| EPS Diluted Continuous Ops | 0.72 | 1.59 | 1.87 | 1.79 | 1.54 |
| EPS Diluted Before Non-Recurring Items | 1.88 | 1.58 | 1.87 | 1.79 | 1.53 |
| EBITDA(a) | $542,132 | $577,315 | $645,838 | $637,514 | $559,487 |